Although Alzheimer’s disease is recognized as a public health problem, only two classes of drugs have been approved to treat it: cholinesterase enzyme inhibitors and N-methyl d-aspartate (NMDA) antagonists [2]. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.